Literature DB >> 34082752

Renin-angiotensin system blockers and COVID-19.

Emmanuelle Vidal-Petiot1,2, Nathalie Gault3,4.   

Abstract

Entities:  

Keywords:  Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; RAS blockers; Renin-angiotensin-aldosterone system; SARS-CoV-2

Year:  2021        PMID： 34082752     DOI： 10.1186/s12916-021-02012-6

Source DB:  PubMed          Journal:  BMC Med        ISSN： 1741-7015            Impact factor:   8.775


× No keyword cloud information.
  7 in total

Review 1.  Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.

Authors:  Jordana B Cohen; Lucy D'Agostino McGowan; Elizabeth T Jensen; Joseph Rigdon; Andrew M South
Journal:  J Hypertens       Date:  2021-04-01       Impact factor: 4.844

2.  Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.

Authors:  Renato D Lopes; Ariane V S Macedo; Pedro G M de Barros E Silva; Renata J Moll-Bernardes; Tiago M Dos Santos; Lilian Mazza; André Feldman; Guilherme D'Andréa Saba Arruda; Denílson C de Albuquerque; Angelina S Camiletti; Andréa S de Sousa; Thiago C de Paula; Karla G D Giusti; Rafael A M Domiciano; Márcia M Noya-Rabelo; Alan M Hamilton; Vitor A Loures; Rodrigo M Dionísio; Thyago A B Furquim; Fábio A De Luca; Ítalo B Dos Santos Sousa; Bruno S Bandeira; Cleverson N Zukowski; Ricardo G G de Oliveira; Noara B Ribeiro; Jeffer L de Moraes; João L F Petriz; Adriana M Pimentel; Jacqueline S Miranda; Bárbara E de Jesus Abufaiad; C Michael Gibson; Christopher B Granger; John H Alexander; Olga F de Souza
Journal:  JAMA       Date:  2021-01-19       Impact factor: 56.272

3.  Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.

Authors:  Alexandre Lahens; Jimmy Mullaert; Simon Gressens; Nathalie Gault; Martin Flamant; Laurène Deconinck; Véronique Joly; Yazdan Yazdanpanah; François-Xavier Lescure; Emmanuelle Vidal-Petiot
Journal:  J Hypertens       Date:  2021-02-01       Impact factor: 4.844

4.  Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review.

Authors:  Katherine Mackey; Valerie J King; Susan Gurley; Michael Kiefer; Erik Liederbauer; Kathryn Vela; Payten Sonnen; Devan Kansagara
Journal:  Ann Intern Med       Date:  2020-05-15       Impact factor: 25.391

5.  Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.

Authors:  Jordana B Cohen; Thomas C Hanff; Preethi William; Nancy Sweitzer; Nelson R Rosado-Santander; Carola Medina; Juan E Rodriguez-Mori; Nicolás Renna; Tara I Chang; Vicente Corrales-Medina; Jaime F Andrade-Villanueva; Alejandro Barbagelata; Roberto Cristodulo-Cortez; Omar A Díaz-Cucho; Jonas Spaak; Carlos E Alfonso; Renzo Valdivia-Vega; Mirko Villavicencio-Carranza; Ricardo J Ayala-García; Carlos A Castro-Callirgos; Luz A González-Hernández; Eduardo F Bernales-Salas; Johanna C Coacalla-Guerra; Cynthia D Salinas-Herrera; Liliana Nicolosi; Mauro Basconcel; James B Byrd; Tiffany Sharkoski; Luis E Bendezú-Huasasquiche; Jesse Chittams; Daniel L Edmonston; Charles R Vasquez; Julio A Chirinos
Journal:  Lancet Respir Med       Date:  2021-01-07       Impact factor: 30.700

6.  Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials.

Authors:  Rodolfo Pedro Rothlin; Mariano Duarte; Facundo Germán Pelorosso; Liliana Nicolosi; M Victoria Salgado; Héctor Miguel Vetulli; Eduardo Spitzer
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

Review 7.  Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.

Authors:  Simon B Gressens; Georges Leftheriotis; Jean-Claude Dussaule; Martin Flamant; Bernard I Levy; Emmanuelle Vidal-Petiot
Journal:  Front Physiol       Date:  2021-02-22       Impact factor: 4.566
  7 in total
  2 in total

Review 1.  Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction.

Authors:  Roxana Mihaela Chiorescu; Roxana-Daiana Lazar; Sándor-Botond Buksa; Mihaela Mocan; Dan Blendea
Journal:  Front Cardiovasc Med       Date:  2022-06-17

Review 2.  Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.

Authors:  Masoumeh Farahani; Zahra Niknam; Leila Mohammadi Amirabad; Nasrin Amiri-Dashatan; Mehdi Koushki; Mohadeseh Nemati; Fahima Danesh Pouya; Mostafa Rezaei-Tavirani; Yousef Rasmi; Lobat Tayebi
Journal:  Biomed Pharmacother       Date:  2021-11-12       Impact factor: 7.419
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.